CRISPR/Cas9 engineering of albino cystinuria Type A mice-Reference-Cited by-同舟云学术

CRISPR/Cas9 engineering of albino cystinuria Type A mice

Published:2020-02-20 Issue:5 Volume:58 Page:
ISSN:1526-954X
Container-title:genesis
language:en
Short-container-title:genesis

Author:

Beckermann Thomas M.¹,Welch Richard C.¹,Williams Felisha M.¹,Mortlock Douglas P.²,Sha Feng¹,Ikizler Talat A.¹²,Woodard Lauren E.¹²³,Wilson Matthew H.¹³⁴^ORCID

Affiliation:

1. Department of Medicine, Division of Nephrology and HypertensionVanderbilt University Medical Center Nashville Tennessee

2. Department of Molecular Physiology and BiophysicsVanderbilt University Nashville Tennessee

3. Department of Veterans AffairsTennessee Valley Health Services Nashville Tennessee

4. Department of PharmacologyVanderbilt University Nashville Tennessee

Funder

U.S. Department of Veterans Affairs

Publisher

Wiley

Subject

Cell Biology,Endocrinology,Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dvg.23357

Reference18 articles.

1. Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection

2. Lung-directed gene therapy in mice using the nonviral Sleeping Beauty transposon system

3. Rapid analysis of amino acids using pre-column derivatization

4. Easy quantitative assessment of genome editing by sequence trace decomposition

5. Cystinuria: mechanisms and management

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of CRISPR/Cas9 technology in mice and livestock genome editing: Current research;Annals of Animal Science;2024-08-29

2. Gene therapy for kidney disease: targeting cystinuria;Current Opinion in Nephrology & Hypertension;2021-12-15

3. The Vanderbilt O’Brien Kidney Center;American Journal of Physiology-Renal Physiology;2021-03-01